Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation

• Published in: Acta neuropathologica 2015-12, Vol.131 (4), p.621-637
• Main Authors: Henderson, Michael X., Wirak, Gregory S., Zhang, Yong-quan, Dai, Feng, Ginsberg, Stephen D., Dolzhanskaya, Natalia, Staropoli, John F., Nijssen, Peter CG, Lam, TuKiet T, Roth, Amy F., Davis, Nicholas G., Dawson, Glyn, Velinov, Milen, Chandra, Sreeganga S.
• Format: Article
• Language: English
• ISSN: 0001-6322; 1432-0533
• DOI: 10.1007/s00401-015-1512-2

Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology ( CLN1-14 ). Recently, mutations in the DNAJC5/CLN4 gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 ( PPT1/CLN1 ) are biochemically linked. We find that in DNAJC5/CLN4 patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSP is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and DNAJC5/CLN4 patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.